RECRUITING Not applicable ClinicalTrials.gov

Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy

Sponsor: Assaf-Harofeh Medical Center • ClinicalTrials.gov ID: NCT06724861

Registry updated: 2026-09-04

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

This study is a cross-over RCT evaluating the effectiveness of 3 sessions a week apart of explicit sensory retraining to the lower extremities in individuals with CIPN versus usual care. The primary outcome measures are TNAS for subjective symptoms, VAS for pain and TUG for mobility. Additional outcome measures are FABS for balance, sensory assessments - monofilaments for touch threshold, LEPT for proprioception, a home exercise log and a satisfaction questionnaire.

Interventions

Explicit Sensory Retraining for the lower extremities (Other)
Sensory retraining of detection, discrimination, quantification of a stimuli and recognition of stimuli and objects with the leg and mainly with the foot. Top-down awareness of bottom-up sensory experience in the treatment session and in everyday life.
no treatment (Other)
Usual care

Eligibility criteria

Inclusion Criteria: * CIPN by self-report (present or absent) \> 3 months after last chemotherapy treatment * age \> 18. Exclusion Criteria: * Pre-chemotherapy neuropathy/ sensory impairment * recurrent falls prior to chemotherapy (more than 2 per year) * CNS involvement * not ambulatory before chemotherapy * Hebrew proficiency not meeting questionnaires' needs.

Conditions

CIPN - Chemotherapy-Induced Peripheral Neuropathy Age Over 18 Chemotherapy-induced Peripheral Neuropathy

Locations

Shamir Medical center — Tzrifin, Israel

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment